Searchable abstracts of presentations at key conferences in endocrinology

ea0034p197 | Nursing practise | SFEBES2014

Integrating a new drug into clinical practice and enhancing the patient experience

Jagger Caroline

Denosumab is a fully human MAB that inhibits bone resorption by neutralizing RANKL and was licensed in 2010 for the treatment of post-menopausal osteoporosis. It was first integrated in a northwest trust, under the care of the metabolic and bone disease department, as a second line treatment.Since 2012 denosumab has been used in the outpatient clinic under a shared care agreement with the greater Manchester medicines management group, this agreement ensu...

ea0031p175 | Nursing practice | SFEBES2013

Using a nursing model in the management of a patient with McCune--Albright syndrome

Jagger Caroline

McCune–Albright syndrome and fibrous dysplasia are a rare sporadic skeletal disorder in which normal bone structures and marrow are replaced by a benign fibrous tissue. The disease can be limited to one or many bones and is more prevalent in females. One of the clinical consequences experienced by patients is severe bone pain for which bisphosphonates are an effective treatment.By the use of a nursing model for the treatment of the patient with this...

ea0028p161 | Nursing practise | SFEBES2012

Changing the nursing practice regarding the administration of Zoledronic acid

Jagger Caroline

Zoledronic acid (5 mg) is used as an annual intravenous infusion for the treatment of post menopausal Osteoporosis, Paget's disease, Hypercalcaemia and more recently complex regional pain syndrome. Zoledronic acid is a potent anti-resorptive preparation used to slow bone breakdown, increase bone density and decrease the amount of Calcium released from the bones into the blood. Previously patients were reviewed in the outpatients clinic whereby bloods tests, Parathyroid hormone...

ea0082wf2 | Workshop F: Disorders of the parathyroid glands, calcium metabolism and bone | SFEEU2022

Secondary osteoporosis

Shaikh Sheeba , Jagger Caroline

Osteoporosis is estimated to effect more than 3 million people in UK and secondary osteoporosis accounts for about 30% of women and 55% of men with vertebral fractures. There are many causes of secondary osteoporosis, such as endocrine, gastrointestinal disorders, steroid use, as well as immobility, obesity, bulimia and anorexia nervosa. We present a case of Osteoporosis secondary to anorexia nervosa.77 year”s old lady initially referred to bone clinic at the age of 46 wi...

ea0034p196 | Nursing practise | SFEBES2014

Treating vitamin D deficiency in coeliac patients

Komlosy Nicci , Jagger Caroline

Vitamin D deficiency has been estimated to affect one billion people world wide1. It is especially prevalent in Coeliac disease which is estimated to affect one in a 100 people. The intolerance to absorb gluten reduces not only the absorption of calcium, but can also further induce secondary hyperparathyroidism, infertility and a small increased risk of bowel carcinoma and osteoporosis.A joint nurse/dietetic Coeliac and Osteoporosis clinic was...